You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ADVIL ALLERGY AND CONGESTION RELIEF Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Advil Allergy And Congestion Relief patents expire, and when can generic versions of Advil Allergy And Congestion Relief launch?

Advil Allergy And Congestion Relief is a drug marketed by Haleon Us Holdings and is included in one NDA.

The generic ingredient in ADVIL ALLERGY AND CONGESTION RELIEF is chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ADVIL ALLERGY AND CONGESTION RELIEF?
  • What are the global sales for ADVIL ALLERGY AND CONGESTION RELIEF?
  • What is Average Wholesale Price for ADVIL ALLERGY AND CONGESTION RELIEF?
Summary for ADVIL ALLERGY AND CONGESTION RELIEF
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 2
Clinical Trials: 310
What excipients (inactive ingredients) are in ADVIL ALLERGY AND CONGESTION RELIEF?ADVIL ALLERGY AND CONGESTION RELIEF excipients list
DailyMed Link:ADVIL ALLERGY AND CONGESTION RELIEF at DailyMed
Drug patent expirations by year for ADVIL ALLERGY AND CONGESTION RELIEF
Recent Clinical Trials for ADVIL ALLERGY AND CONGESTION RELIEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Allergy & Asthma Medical Group & Research CenterPhase 2
Windtree TherapeuticsPhase 1/Phase 2
Asan Medical CenterPhase 3

See all ADVIL ALLERGY AND CONGESTION RELIEF clinical trials

US Patents and Regulatory Information for ADVIL ALLERGY AND CONGESTION RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings ADVIL ALLERGY AND CONGESTION RELIEF chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022113-001 Dec 21, 2011 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ADVIL ALLERGY AND CONGESTION RELIEF Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Advil Allergy and Congestion Relief

Introduction to Advil Allergy and Congestion Relief

Advil Allergy and Congestion Relief is a multi-symptom medication designed to combat tough allergy and sinus symptoms. Each tablet contains ibuprofen (200mg), an anti-inflammatory pain reliever and fever reducer; phenylephrine HCl (10mg), a nasal decongestant; and chlorpheniramine maleate (4mg), an antihistamine. These components work together to alleviate symptoms such as runny nose, sneezing, sinus pressure, nasal congestion, itchy eyes, headache, and minor body aches[1][2][5].

Market Context: Ibuprofen and OTC Medications

The global ibuprofen market, which includes products like Advil Allergy and Congestion Relief, is experiencing significant growth. Valued at USD 1.43 billion in 2023, the market is projected to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44%[3].

Another report indicates a more aggressive growth rate, with the ibuprofen market expected to reach USD 205.6 million by 2033 from USD 97 million in 2023, at a CAGR of 7.8%[4].

Key Drivers of Market Growth

Several factors are driving the growth of the ibuprofen market, and by extension, products like Advil Allergy and Congestion Relief:

Increasing Chronic Pain Conditions

The rising prevalence of chronic pain conditions such as rheumatoid arthritis and osteoarthritis is a significant driver. These conditions require effective pain management and inflammation reduction, for which ibuprofen is a preferred choice[4].

Growing Healthcare Awareness and Spending

Rising public awareness of chronic diseases and increasing healthcare spending are contributing to the demand for over-the-counter (OTC) medications like Advil Allergy and Congestion Relief[3].

Self-Medication Trend

The trend toward self-medication for minor ailments is also boosting the demand for OTC ibuprofen products. Consumers are increasingly opting for self-medication, which favors the growth of the OTC market[4].

Market Segmentation and Application

Formulation Types

The ibuprofen market is segmented into various formulations, with tablets leading the market share due to their ease of use. Advil Allergy and Congestion Relief tablets, being portable and convenient, align well with this trend[4].

Application Areas

The product is particularly effective in addressing symptoms associated with hay fever, other upper respiratory allergies, and the common cold. It is also used for pain relief, fever reduction, and managing minor body aches[5].

Competitive Landscape

The market for allergy and congestion relief medications is competitive, with several brands offering similar products. However, Advil's reputation and the multi-symptom relief offered by Advil Allergy and Congestion Relief give it a competitive edge.

Financial Trajectory

Given the growth projections of the ibuprofen market, products like Advil Allergy and Congestion Relief are likely to see increased sales and revenue. Here are some key financial indicators:

Market Size and Growth

The overall ibuprofen market is expected to grow significantly, with some reports indicating a CAGR of 7.8% from 2024 to 2033. This growth will likely translate into higher sales for Advil Allergy and Congestion Relief[4].

Revenue Projections

While specific revenue projections for Advil Allergy and Congestion Relief are not available, the overall growth of the ibuprofen market suggests that this product will contribute substantially to the revenue of its manufacturer.

Challenges and Opportunities

Regulatory Challenges

Regulatory scrutiny and approval processes can pose challenges to the introduction of new or innovative ibuprofen products. However, established products like Advil Allergy and Congestion Relief are less likely to be affected by these challenges[4].

Emerging Markets

The untapped potential in emerging markets presents a significant growth opportunity. Increased healthcare awareness and rising disposable incomes in these regions can drive the demand for Advil Allergy and Congestion Relief[4].

Innovations in Drug Delivery Systems

Advancements in drug delivery systems, such as sustained-release formulations, can enhance patient compliance and convenience, further driving the adoption of these products[4].

Consumer Preferences and Behavior

Consumers increasingly prefer portable and convenient medication options, which aligns well with the design of Advil Allergy and Congestion Relief tablets. The product's ability to provide multi-symptom relief in one pill also appeals to consumers looking for comprehensive allergy and sinus symptom management[1][2][5].

Storage and Usage Guidelines

To ensure the effectiveness and safety of Advil Allergy and Congestion Relief, it is important to follow the recommended storage conditions (between 68 and 77 degrees Fahrenheit) and usage guidelines (one tablet every 4 hours, not exceeding 6 tablets in 24 hours)[5].

Key Takeaways

  • Market Growth: The ibuprofen market, including products like Advil Allergy and Congestion Relief, is expected to grow significantly due to rising chronic pain conditions and increasing healthcare awareness.
  • Competitive Edge: Advil Allergy and Congestion Relief offers multi-symptom relief, making it a competitive product in the market.
  • Financial Projections: The product is likely to contribute to increased revenue for its manufacturer due to the overall growth of the ibuprofen market.
  • Challenges and Opportunities: Regulatory challenges exist, but emerging markets and innovations in drug delivery systems present significant growth opportunities.

Frequently Asked Questions (FAQs)

Q: What are the active ingredients in Advil Allergy and Congestion Relief? A: The active ingredients include ibuprofen (200mg), phenylephrine HCl (10mg), and chlorpheniramine maleate (4mg)[1][2][5].

Q: How often can I take Advil Allergy and Congestion Relief? A: Adults and children 12 years of age and older can take one tablet every 4 hours, not exceeding 6 tablets in any 24-hour period unless directed by a doctor[5].

Q: Can I take Advil Allergy and Congestion Relief with other medications? A: It is not recommended to take this product with any other product containing ibuprofen, pseudoephedrine, phenylephrine, or chlorpheniramine. There is also a drug interaction precaution with monoamine oxidase inhibitors (MAOIs)[5].

Q: How should I store Advil Allergy and Congestion Relief? A: Store the product between 68 and 77 degrees Fahrenheit. Do not refrigerate the product[5].

Q: Is Advil Allergy and Congestion Relief eligible for FSA and HSA reimbursement? A: Yes, this product may be eligible for Flexible Spending Account (FSA) and Health Savings Account (HSA) reimbursement[1][2].

Cited Sources

  1. Rite Aid - Advil Allergy & Congestion Relief Coated Tablets - 10 ct
  2. Mariano’s - Advil Allergy and Congestion Relief Chlorpheniramine Maleate Medicine
  3. Straits Research - Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report
  4. Market.US - Ibuprofen Market Size, Share, Growth | CAGR Of 7.8%
  5. Advil - Advil Allergy and Congestion Relief

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.